AXSM · Axsome Therapeutics, Inc. · Debt

$145.04 -11.03 (-7.07%) At close · Oct 23

Market Cap

$7.60B

52.38M

Volume · Oct 23 1.59M Avg daily vol (3M) 738.87K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Current portion of long-term debt	2026-06-30	USD 70,000,000	10-Q filed 2026-08-10
Finance lease liabilities	2026-06-30	USD 14,515,000	10-Q filed 2026-08-10
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current finance lease liabilities USD 5,485,000 Noncurrent finance lease liabilities USD 9,030,000
Noncurrent debt carrying amount	2026-06-30	USD 117,958,000	10-Q filed 2026-08-10
Operating lease liabilities	2026-06-30	USD 22,220,000	10-Q filed 2026-08-10
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current operating lease liabilities USD 646,000 Noncurrent operating lease liabilities USD 21,574,000

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1579428 CUSIP 05464T104 13F (30d) 67 filings 63 filers Visit website Investor relations